Abstract
Fluoroquinolones (FQ) are an important family of synthetic antimicrobial agents being clinically used over the past thirty years. Currently some FQ are under investigation for the treatment of multidrug-resistant tuberculosis (MDRTB), defined as resistance to at least isoniazid and rifampicin, and are under investigation as first-line drugs. Their main biological target in Mycobacterium tuberculosis is the DNA gyrase, a topoisomerase II encoded by gyrA and gyrB that is essential to maintain the DNA supercoil. It has been demonstrated that mutations in short regions of DNA gyrase are associated with quinolone resistance or hypersusceptibility and take place in several MDR clinical isolates of M. tuberculosis. In this article we update§ our previous review (Carta et al. Anti-infective agents, 2008, 7, 134-147) about the anti mycobacterial properties, mode of action and structure activity relationship (SAR) studies of the known quinolone derivatives. Furthermore, we update the synthesis and activity of 3,9-disubstituted-6-oxo-6,9-dihydro-3H-[1,2,3]-triazolo[4,5-h,g]quinolonecarboxylic acids and their esters as a new class of potent and selective anti-mycobacterial agents, coupled with absence of cytotoxicity. Furthermore, particularly interesting is their activity against MDR M. tuberculosis.
Keywords: Anti-mycobacterial activity, DNA gyrase inhibitors, MDR-TB, quinolones, SAR analysis, triazoloquinolones antitubercular activity.
Anti-Infective Agents
Title:SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update
Volume: 11 Issue: 1
Author(s): Irene Briguglio, Sandra Piras, Paola Corona, Maria A. Pirisi, Daniela Jabes and Antonio Carta
Affiliation:
Keywords: Anti-mycobacterial activity, DNA gyrase inhibitors, MDR-TB, quinolones, SAR analysis, triazoloquinolones antitubercular activity.
Abstract: Fluoroquinolones (FQ) are an important family of synthetic antimicrobial agents being clinically used over the past thirty years. Currently some FQ are under investigation for the treatment of multidrug-resistant tuberculosis (MDRTB), defined as resistance to at least isoniazid and rifampicin, and are under investigation as first-line drugs. Their main biological target in Mycobacterium tuberculosis is the DNA gyrase, a topoisomerase II encoded by gyrA and gyrB that is essential to maintain the DNA supercoil. It has been demonstrated that mutations in short regions of DNA gyrase are associated with quinolone resistance or hypersusceptibility and take place in several MDR clinical isolates of M. tuberculosis. In this article we update§ our previous review (Carta et al. Anti-infective agents, 2008, 7, 134-147) about the anti mycobacterial properties, mode of action and structure activity relationship (SAR) studies of the known quinolone derivatives. Furthermore, we update the synthesis and activity of 3,9-disubstituted-6-oxo-6,9-dihydro-3H-[1,2,3]-triazolo[4,5-h,g]quinolonecarboxylic acids and their esters as a new class of potent and selective anti-mycobacterial agents, coupled with absence of cytotoxicity. Furthermore, particularly interesting is their activity against MDR M. tuberculosis.
Export Options
About this article
Cite this article as:
Briguglio Irene, Piras Sandra, Corona Paola, A. Pirisi Maria, Jabes Daniela and Carta Antonio, SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update, Anti-Infective Agents 2013; 11 (1) . https://dx.doi.org/10.2174/22113626130109
DOI https://dx.doi.org/10.2174/22113626130109 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking
Mini-Reviews in Medicinal Chemistry Theoretical Modeling of HPV: QSAR and Novodesign with Fragment Approach
Current Computer-Aided Drug Design Artemisia Species as Potential Weapon Against Agents and Agricultural Pests
Current Biotechnology Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria
Current Topics in Medicinal Chemistry Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid Derivatives
Medicinal Chemistry Antigen Discovery for Serological Diagnosis of Visceral Leishmaniasis
Current Chemical Biology New Agents Promote Neuroprotection in Parkinson’s Disease Models
CNS & Neurological Disorders - Drug Targets Virtual Screening on Analogs of 2 Methyl Heptyl Isonicotinate as GlmU Inhibitors of Mycobacterium tuberculosis
Current Enzyme Inhibition <i>Ajuga</i> L.: A Systematic Review on Chemical Composition, Phytopharmacological and Biological Potential
Current Bioactive Compounds The role of interleukin 35 in atherosclerosis
Current Pharmaceutical Design Dendritic Cells in Pathogenesis of COPD
Current Pharmaceutical Design Overview of Coumarins and its Derivatives: Synthesis and Biological Activity
Letters in Organic Chemistry Synthesis, Cytotoxicity, Antibacterial and Antileishmanial Activities of Imidazolidine and Hexahydropyrimidine Derivatives
Medicinal Chemistry Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR
CNS & Neurological Disorders - Drug Targets Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity
Letters in Drug Design & Discovery Targeting Bacterial RNA Polymerase σ70 for Development of Broadspectrum Antisense Antibacterials
Recent Patents on Anti-Infective Drug Discovery A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione
Current Computer-Aided Drug Design Exploring Promising Immunomodulatory Potential of Natural and Synthetic 1,3-Diphenyl-2-propen-1-one Analogs: A Review of Mechanistic Insight
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Infective Drug Discovery